Abbott Laboratories (ABT)vsKoninklijke Philips NV ADR (PHG)
ABT
Abbott Laboratories
$105.46
-1.61%
HEALTHCARE · Cap: $191.06B
PHG
Koninklijke Philips NV ADR
$26.25
-2.27%
HEALTHCARE · Cap: $27.08B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 149% more annual revenue ($44.33B vs $17.83B). ABT leads profitability with a 14.7% profit margin vs 5.0%. PHG appears more attractively valued with a PEG of 0.36. ABT earns a higher WallStSmart Score of 51/100 (C-).
ABT
Buy51
out of 100
Grade: C-
PHG
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-323.7%
Fair Value
$25.30
Current Price
$105.46
$80.16 premium
Margin of Safety
-340.5%
Fair Value
$7.28
Current Price
$26.25
$18.97 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 21.6%
Generating 2.6B in free cash flow
Growing faster than its price suggests
Revenue surging 110.0% year-over-year
Reasonable price relative to book value
Generating 1.3B in free cash flow
Areas to Watch
Expensive relative to growth rate
Moderate valuation
4.4% revenue growth
Weak financial health signals
Moderate valuation
ROE of 7.8% — below average capital efficiency
5.0% margin — thin
Earnings declined 50.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : PHG
The strongest argument for PHG centers on PEG Ratio, Revenue Growth, Price/Book. Revenue growth of 110.0% demonstrates continued momentum. PEG of 0.36 suggests the stock is reasonably priced for its growth.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, Revenue Growth.
Bear Case : PHG
The primary concerns for PHG are P/E Ratio, Return on Equity, Profit Margin.
Key Dynamics to Monitor
ABT profiles as a value stock while PHG is a hypergrowth play — different risk/reward profiles.
PHG carries more volatility with a beta of 0.94 — expect wider price swings.
PHG is growing revenue faster at 110.0% — sustainability is the question.
ABT generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
ABT scores higher overall (51/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Koninklijke Philips NV ADR
HEALTHCARE · MEDICAL DEVICES · USA
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?